NO904372D0 - Fremgangsmaate for fremstilling av nye alfa-glucosidaseinhibitorer. - Google Patents

Fremgangsmaate for fremstilling av nye alfa-glucosidaseinhibitorer.

Info

Publication number
NO904372D0
NO904372D0 NO904372A NO904372A NO904372D0 NO 904372 D0 NO904372 D0 NO 904372D0 NO 904372 A NO904372 A NO 904372A NO 904372 A NO904372 A NO 904372A NO 904372 D0 NO904372 D0 NO 904372D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
glucosidase inhibitors
new
new alfa
Prior art date
Application number
NO904372A
Other languages
English (en)
Other versions
NO174203C (no
NO174203B (no
NO904372L (no
Inventor
Jean-Bernard Ducep
Charles Danzin
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO904372D0 publication Critical patent/NO904372D0/no
Publication of NO904372L publication Critical patent/NO904372L/no
Publication of NO174203B publication Critical patent/NO174203B/no
Publication of NO174203C publication Critical patent/NO174203C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044Pyrrole radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Child & Adolescent Psychology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO904372A 1989-10-10 1990-10-09 Analogifremgangsmåte for fremstilling av terapeutisk aktive NO174203C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89402794A EP0422307A1 (en) 1989-10-10 1989-10-10 Novel alpha-glucosidase inhibitors

Publications (4)

Publication Number Publication Date
NO904372D0 true NO904372D0 (no) 1990-10-09
NO904372L NO904372L (no) 1991-04-11
NO174203B NO174203B (no) 1993-12-20
NO174203C NO174203C (no) 1994-04-06

Family

ID=8202997

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904372A NO174203C (no) 1989-10-10 1990-10-09 Analogifremgangsmåte for fremstilling av terapeutisk aktive

Country Status (21)

Country Link
US (1) US5097023A (no)
EP (2) EP0422307A1 (no)
JP (1) JP3032266B2 (no)
KR (1) KR0183012B1 (no)
CN (1) CN1029974C (no)
AR (1) AR246745A1 (no)
AT (1) ATE109153T1 (no)
AU (1) AU632855B2 (no)
CA (1) CA2027276C (no)
DE (1) DE69011033T2 (no)
DK (1) DK0422975T3 (no)
ES (1) ES2060980T3 (no)
FI (1) FI101796B1 (no)
HU (1) HU209724B (no)
IE (1) IE64079B1 (no)
IL (1) IL95928A (no)
NO (1) NO174203C (no)
NZ (1) NZ235578A (no)
PT (1) PT95547B (no)
TW (1) TW225539B (no)
ZA (1) ZA907936B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504078A (en) * 1990-06-08 1996-04-02 Merrell Dow Pharmaceuticals Inc. α-glucosidase inhibitors
US5268364A (en) * 1991-12-12 1993-12-07 The Biomembrane Institute Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by O-glycosylation modification
US5605893A (en) * 1994-03-15 1997-02-25 Children's Hospital Of Los Angeles Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
US5843921A (en) 1994-03-15 1998-12-01 Childrens Hospital Of Los Angeles Therapeutic food composition and method to diminish blood sugar fluctuations
JP3580900B2 (ja) * 1995-04-20 2004-10-27 ホクレン農業協同組合連合会 α−グルコシダーゼ阻害剤を含む糖を主体とする組成物を有効成分とする食品及び飼料
US5929037A (en) * 1995-06-07 1999-07-27 Alberta Research Council Modified α-D-Glcρ-(1-2)-α-D-Glcρ-(1-3)-α-D-Glcρ-analogues
WO1997009040A1 (en) * 1995-09-08 1997-03-13 Novo Nordisk A/S 2-alkylpyrrolidines
AU4335997A (en) * 1996-09-09 1998-03-26 Wisconsin Alumni Research Foundation Human salivary proteins and fragments thereof having alpha-glucosidase inhibitory activity
US6534487B1 (en) 1999-08-03 2003-03-18 Childrens Hospital Los Angeles Methods for suppressing appetite and enhancing exercise and recovery
US7091221B2 (en) * 1999-12-21 2006-08-15 Ajinomoto Co., Inc. Partial ester of cellulose with nitrogenous carboxylic acid and process for producing the same
JP4486792B2 (ja) * 2003-06-12 2010-06-23 学校法人近畿大学 環状オニウム化合物およびグルコシダーゼ阻害剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.

Also Published As

Publication number Publication date
EP0422975A1 (en) 1991-04-17
DE69011033T2 (de) 1994-11-17
IE903613A1 (en) 1991-04-24
NZ235578A (en) 1992-10-28
EP0422307A1 (en) 1991-04-17
IL95928A (en) 1994-08-26
HUT55402A (en) 1991-05-28
HU209724B (en) 1994-10-28
NO174203C (no) 1994-04-06
TW225539B (no) 1994-06-21
ES2060980T3 (es) 1994-12-01
FI101796B (fi) 1998-08-31
AU6375690A (en) 1991-04-18
JP3032266B2 (ja) 2000-04-10
PT95547B (pt) 1998-02-27
CN1029974C (zh) 1995-10-11
KR910007951A (ko) 1991-05-30
FI904965A0 (fi) 1990-10-09
FI101796B1 (fi) 1998-08-31
HU906389D0 (en) 1991-04-29
CA2027276C (en) 2000-05-16
AU632855B2 (en) 1993-01-14
CA2027276A1 (en) 1991-04-11
IE64079B1 (en) 1995-07-12
JPH03127797A (ja) 1991-05-30
NO174203B (no) 1993-12-20
DK0422975T3 (da) 1994-08-22
US5097023A (en) 1992-03-17
ZA907936B (en) 1991-08-28
EP0422975B1 (en) 1994-07-27
DE69011033D1 (de) 1994-09-01
IL95928A0 (en) 1991-07-18
CN1050879A (zh) 1991-04-24
KR0183012B1 (ko) 1999-04-01
NO904372L (no) 1991-04-11
ATE109153T1 (de) 1994-08-15
AR246745A1 (es) 1994-09-30
PT95547A (pt) 1991-08-14

Similar Documents

Publication Publication Date Title
NO892230D0 (no) Fremgangsmaate for fremstilling av nye alfa-glucosidaseinhibitorer.
NO903314L (no) Fremgangsmaate for fremstilling av nye peptidaseinhibitorer
NO871277L (no) Fremgangsmaate for fremstilling av nye oxadiazoler.
NO905255L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte acylaminotiazoler.
NO873091D0 (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO904059L (no) Fremgangsmaate for fremstilling av nye substituerte isokinoliner.
NO902776L (no) Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer.
NO904372D0 (no) Fremgangsmaate for fremstilling av nye alfa-glucosidaseinhibitorer.
NO863139D0 (no) Fremgangsmaate ved fremstilling av nye benzamider.
NO901813D0 (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO913391D0 (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
NO880851D0 (no) Fremgangsmaate for fremstilling av nye renin-inhibitorer.
FI904676A0 (fi) Anordning foer loesgoerande av manteln i en haeftapparat.
NO904069L (no) Fremgangsmaate for fremstilling av nye alkanofenoner.
NO911118D0 (no) Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner.
NO854577L (no) Fremgangsmaate for fremstilling av nye tienopyridinderivater.
NO890644D0 (no) Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer.
NO900432D0 (no) Fremgangsmaate for fremstilling av nye aryl- eller heteroaryl-1-alkyl-pyrrol-2-carboxylsyreforbindelser.
NO901422D0 (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
NO860538L (no) Fremgangsmaate ved fremstilling av nye antiallergisk virksomme substanser.
NO871721L (no) Fremgangsmaate for fremstilling av nye ergolenderivater.
NO900935L (no) Fremgangsmaate for fremstilling av nye piperidinderivater.
NO893006D0 (no) Fremgangsmaate for fremstilling av nye allylaminoetylazoler
NO902967L (no) Fremgangsmaate til fremstilling av nye sulfamoyl-tiofener.
NO901401D0 (no) Fremgangsmaate for fremstilling av nye 1-difenylmethylpiperidinderivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2001